不同病原菌化脓性脑膜炎患儿的临床特点对比分析

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (0 KB) HTML (44 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical characteristics,pathogen distribution,treatment and outcome of purulent meningitis in neonates in order to provide the guide for early diagnosis and appropriate treatment.Methods The case data of 134 newborn children with purulent meningitis who were admitted to Fujian Maternity and Child Health Hospital from January 1,2014 to December 31,2016 were retrospectively analyzed.According to the results of blood culture or cerebrospinal fluid (CSF) culture,the subjects were divided into the Streptococcus agalactiae (GBS) group (15 cases),the other bacteria group (14 cases),and the unknown pathogen group (105 caces),and the clinical characteristics of each group were compared.Results The main clinical manifestations of purulent meningitis were fever,shortness of breath and jaundice,fever was the most common symptom.The positive rate of blood and cerebrospinal fluid culture was low,mainly GBS and Escherichia coli.C-reactive protein (CRP) levels in the GBS group and the other bacteria group were higher than those in the unknown pathogen group,and the differences were statistically significant (P＜0.05).The cerebrospinal fluid white blood cell counts of the other bacteria group and the GBS group were higher than those of the unknown pathogen group,the percentage of CSF polykaryotic cells in the GBS group was higher than that in the other bacteria group and the unknown pathogen group,and the differences were statistically significant (P＜0.05).There were 30 cases with CSF protein exceeding 1.88 g/L,among whom 13 cases had complications.A total of 83 cases were cured,44 cases were improved,2 cases were complicated with subdural effusion for further treatment by neurosurgery,and 5 cases were abandoned due to severe complications.Conclusion The clinical manifestations of neonatal purulent meningitis are lack of specificity,fever is the most common symptom.The main pathogens are GBS and Escherichia coli,and GBS infection should be considered if CRP,the percentage of leukocytes and polynuclear cells in CSF increase significantly.

Key words： Meningitis Bacterial Neonate Etiology Treatment outcome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Zhi-qing
	ZHOU Dan
	LIN Fang-fang

Cite this article:

CHEN Zhi-qing,ZHOU Dan,LIN Fang-fang. Comparative analysis of clinical characteristics of neonates with purulent meningitis caused by different pathogens[J]. 中国当代医药, 2020, 27(30): 13-17.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I30/13

[3]	曹云，程国强，侯新琳，等.新生儿细菌性脑膜炎病因、诊断与治疗[J].中华围产医学杂志，2016，19（12）：881-884.
[4]	李珊，王颖.新生儿细菌性脑膜炎的诊治及观点更新[J].中国小儿急救医学，2017，24（5）：326-329.
[5]	邵肖梅，叶鸿瑁，丘小汕.实用新生儿学[M].4版.北京：人民卫生出版社，2011：347-351.
[7]	新生儿细菌性脑膜炎多中心研究协作组.华南部分地区新生儿细菌性脑膜炎多中心流行病学研究[J].中华儿科杂志，2018，56（6）：421-428.
[1]	Brouwer MC，Tunkel AR，van de Beek D.Epidemiology，diagnosis，and antimicrobial treatment of acute bacterial meningitis[J].Clin Microbiol Rev，2010，23（3）：467-492.
[2]	Di Mauro A，Cortese F，Laforgia N，et al.Neonatal bacterial meningitis：a systematic review of European available data[J].Minerva Pediatr，2019，71（2）：201-208.
[6]	Lin MC，Chiu NC，Chi H，et al.Evolving trends of neonatal and childhood bacterial meningitis in northern Taiwan[J].J Microbiol Immunol Infect，2015，48（3）：296-301.
[8]	Kumar M，Tripathi S，Kumar H，et al.Predictors of Poor Outcome in Neonates with Pyogenic Meningitis in a Level-Three Neonatal Intensive Care Unit of Developing Country[J].J Trop Pediatr，2018，64（4）：297-303.
[9]	Ku LC，Boggess KA，Cohen-Wolkowiez M.Bacterial meningitis in infants[J].Clin Perinatol，2015，42（1）：29-45.
[10]	刘梦迪，徐发林，段稳丽，等.新生儿细菌性脑膜炎预后不良的危险因素分析[J].中国当代儿科杂志，2019，21（11）：1064-1068.
[11]	Bedetti L，Marrozzini L，Baraldi A，et al.Pitfalls in the diagnosis of meningitis in neonates and young infants：the role of lumbar puncture[J].J Matern Fetal Neonatal Med，2019，32（23）：4029-4035.
[12]	Cortese F，Scicchitano P，Gesualdo M，et al.Early and Late Infections in Newborns：Where Do We Stand?A Review[J].Pediatr Neonatol，2016，57（4）：265-273.
[13]	Tan J，Kan J，Qiu G，et al.Clinical Prognosis in Neonatal Bacterial Meningitis：The Role of Cerebrospinal Fluid Protein[J].PLoS One，2015，10（10）：e0141620.
[14]	El-Naggar W，Afifi J，McMillan D，et al.Epidemiology of Meningitis in Canadian Neonatal Intensive Care Units[J].Pediatr Infect Dis J，2019，38（5）：476-480.
[15]	赵小林，郭金珍，李占魁.足月儿与早产儿细菌性脑膜炎的临床分析[J].中国当代儿科杂志，2019，21（10）：1044-1048.
[16]	de Gier B，van Kassel MN，Sanders EAM，et al.Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands[J].PLoS One，2019，14（5）：e0216749.
[17]	Whittaker R，Economopoulou A，Dias JG，et al.European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease.Epidemiology of Invasive Haemophilus influenzae Disease，Europe，2007-2014[J].Emerg Infect Dis，2017，23（3）：396-404.
[18]	Zhao Z，Yu JL，Zhang HB，et al.Five-Year Multicenter Study of Clinical Tests of Neonatal Purulent Meningitis[J].Clin Pediatr （Phila），2018，57（4）：389-397.
[19]	Le Doare K，O′Driscoll M，Turner K，et al.Intrapartum Antibiotic Che-moprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide：Systematic Review[J].Clin Infect Dis，2017，65（2）：S143-S151.
[20]	Heath PT，Culley FJ，Jones CE，et al.Group B streptococcus and respiratory syncytial virus immunisation during pregnancy：a landscape analysis[J].Lancet Infect Dis，2017，17（7）：e223-e234.
[21]	Germovsek E，Lutsar I，Kipper K，et al.Plasma and CSF pharmacokinetics of meropenem in neonates and young infants：results from the NeoMero studies[J].J Antimicrob Chemother，2018，73（7）：1908-1916.